small molecule

INJECTAFER

FERRIC CARBOXYMALTOSE

Loss of exclusivityFebruary 2028latest FDA-listed patent expiry

CompanyAMERICAN REGENT INC

Drug detail

Brand name	INJECTAFER
Active ingredient	FERRIC CARBOXYMALTOSE
Strength	500MG IRON/10ML (50MG IRON/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	October 2020
Marketing status	RX

Listed patents

Patent	Expires	Type
7754702	February 2028	use U-3312
7612109	February 2027	substance, product
11478502	January 2027	use U-3474
11433091	January 2027	use U-3634
11364260	January 2027	use U-3637
8895612	January 2027	use U-3315

Regulatory exclusivity

Code	Expires
I-915	May 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from AMERICAN REGENT INC